secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001185185-24-000301
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma enters ATM sales agreement for up to $60M in common stock
--------------------------------------------------------------------

- Agreement with A.G.P./Alliance Global Partners allows at-the-market sales of up to $60 million in common stock.
- Board initially reserved 171,428,571 shares based on $0.35 reference price; commission set at 3.0% of gross proceeds.
- Sales may occur from time to time via NYSE American; agent not obligated to purchase shares on principal basis.
- Annual maintenance fee of $10,000 payable to sales agent; agreement terminates after three years or earlier by notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000301/0001185185-24-000301-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000301/igcpharma20240320c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-24-000301

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer